Voltar
Revisão Acesso aberto Revisado por pares
BIBTEX RIS

Myeloid-derived suppressor cells in ovarian cancer: friend or foe?

2017; Termedia Publishing House; Volume: 42; Issue: 4 Linguagem: Inglês

10.5114/ceji.2017.72823

ISSN

1644-4124

Autores

Monika Walankiewicz, Ewelina Grywalska, Grzegorz Polak, Jan Kotarski, Dorota Siwicka-Gieroba, Jacek Roliński,

Tópico(s)

Immune Response and Inflammation

Resumo

ENWEndNote BIBJabRef, Mendeley RISPapers, Reference Manager, RefWorks, Zotero AMA Walankiewicz M, Grywalska E, Polak G, Kotarski J, Siwicka-Gieroba D, Roliński J. Myeloid-derived suppressor cells in ovarian cancer: friend or foe?. Central European Journal of Immunology. 2017;42(4):383-389. doi:10.5114/ceji.2017.72823. APA Walankiewicz, M., Grywalska, E., Polak, G., Kotarski, J., Siwicka-Gieroba, D., & Roliński, J. (2017). Myeloid-derived suppressor cells in ovarian cancer: friend or foe?. Central European Journal of Immunology, 42(4), 383-389. https://doi.org/10.5114/ceji.2017.72823 Chicago Walankiewicz, Monika, Ewelina Grywalska, Grzegorz Polak, Jan Kotarski, Dorota J. Siwicka-Gieroba, and Jacek Roliński. 2017. "Myeloid-derived suppressor cells in ovarian cancer: friend or foe?". Central European Journal of Immunology 42 (4): 383-389. doi:10.5114/ceji.2017.72823. Harvard Walankiewicz, M., Grywalska, E., Polak, G., Kotarski, J., Siwicka-Gieroba, D., and Roliński, J. (2017). Myeloid-derived suppressor cells in ovarian cancer: friend or foe?. Central European Journal of Immunology, 42(4), pp.383-389. https://doi.org/10.5114/ceji.2017.72823 MLA Walankiewicz, Monika et al. "Myeloid-derived suppressor cells in ovarian cancer: friend or foe?." Central European Journal of Immunology, vol. 42, no. 4, 2017, pp. 383-389. doi:10.5114/ceji.2017.72823. Vancouver Walankiewicz M, Grywalska E, Polak G, Kotarski J, Siwicka-Gieroba D, Roliński J. Myeloid-derived suppressor cells in ovarian cancer: friend or foe?. Central European Journal of Immunology. 2017;42(4):383-389. doi:10.5114/ceji.2017.72823.

Referência(s)